Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJB6 pseudogene 2 (DNAJB6P2) appears to refer to a pseudogene related to the protein-coding gene DNAJB6 (DnaJ heat shock protein family [Hsp40] member B6)[1][6]. There is no evidence in the provided results that DNAJB6P2 encodes an active protein, participates in biological pathways, or is itself considered a therapeutic target. DNAJB6P2 is a noncoding genomic sequence related by homology to the DNAJB6 gene, which encodes a molecular chaperone of the Hsp40 family involved in protein folding, aggregation suppression, and myopathy[1][6]. DNAJB6P2 itself is annotated as a pseudogene, indicating it does not code for a functional protein and currently has no established molecular, biological, or disease relevance. The main gene, *DNAJB6*, is an important protein-coding gene involved in chaperone function, protein aggregation suppression, and muscle disease, but DNAJB6P2, by virtue of being a pseudogene, does not share these properties[1][2][4][5][6]. No evidence was found for DNAJB6P2 being considered a protein, therapeutic target, or disease biomarker; this entry seems to be an error or refers to a nonfunctional locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNAJB6 pseudogene 2 (DNAJB6P2).